🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the proportion of subjects with HIV...
Status
Completed
Location
Local Institution
Start Date
2005-11
Trial ID
NCT00207142
Treatments Being Tested
The purpose of this study is to characterise the pharmacokinetic profiles o...
Status
Completed
Location
Germans Trias i Pujol Hospital
Start Date
2005-01
Trial ID
NCT00307502
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01458769
The U.S. Department of Health and Human Services (HHS) guidelines recommend...
Status
Completed
Location
USC CRS
Start Date
2009-06
Trial ID
NCT00851799
Treatments Being Tested
The purpose of this study is to assess the exposure of Atazanavir 400 mg wi...
Status
Completed
Location
Local Institution
Start Date
2006-07
Trial ID
NCT00357188
Treatments Being Tested
This study compared 3 different three-drug combinations in HIV infected ind...
Status
Completed
Location
University of Southern California
Start Date
2005-05
Trial ID
NCT00084136
This study was designed to test the efficacy, safety, tolerability and dura...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03
Trial ID
NCT00440947
This randomized trial compares the efficacy of switching to a fixed-dose co...
Status
Unknown
Location
GHESKIO
Start Date
2020-09-01
Trial ID
NCT04311957
Treatments Being Tested
This study will examine drug and body interactions in children receiving an...
Status
Completed
Location
Univ. of Alabama Birmingham NICHD CRS (5096)
Start Date
2002-08
Trial ID
NCT00977756
MODERATO is a phase III, open-label, randomized, multicenter, non-inferiori...
Status
Unknown
Location
Hôpital de jour, Service des maladies infectieuses, CHU Sourô Sanou
Start Date
2020-09-21
Trial ID
NCT04022967